cbdMD (YCBD) Current Deferred Revenue (2017 - 2026)
cbdMD (YCBD) posted Current Deferred Revenue of $488626.0 for Q4 2025, down 3.49% sequentially from $506289.0 in Q3 2025, and down 7.36% YoY from $527438.0 in Q4 2024.
cbdMD (YCBD) Current Deferred Revenue (2017 - 2026) Analysis & Trends
cbdMD has reported Current Deferred Revenue for 8 years, with the latest figure at $488626.0 in Q4 2025.
- Quarterly Current Deferred Revenue fell 7.36% year-over-year to $488626.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $488626.0 (down 7.36% YoY) and the FY2025 annual result came in at $506289.0, up 0.6% from the prior year.
- Current Deferred Revenue fell to $488626.0 in Q4 2025 per YCBD's latest filing, from $506289.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $557353.0 in Q1 2025 and troughed at $755.0 in Q2 2021.
- A 4-year average of $429667.4 and a median of $504771.5 in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue jumped 171.67% in 2024, then fell 7.43% in 2025.
- Over 4 years, Current Deferred Revenue stood at $755.0 in 2021, then jumped by 24435.89% to $185246.0 in 2023, then jumped by 184.72% to $527438.0 in 2024, then retreated by 7.36% to $488626.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $488626.0, $506289.0, and $509198.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 570,251.00 |
| Dec 31, 2025 | 488,626.00 |
| Sep 30, 2025 | 506,289.00 |
| Jun 30, 2025 | 509,198.00 |
| Mar 31, 2025 | 557,353.00 |
| Dec 31, 2024 | 527,438.00 |
| Sep 30, 2024 | 503,254.00 |
| Jun 30, 2024 | 550,043.00 |
| Mar 31, 2024 | 468,472.00 |
| Sep 30, 2023 | 185,246.00 |
| Jun 30, 2021 | 755.00 |
| Dec 31, 2020 | 22,440.00 |
| Jun 30, 2019 | 4,585.00 |
| Mar 31, 2019 | 33,333.00 |
| Dec 31, 2018 | 47,083.00 |
| Sep 30, 2018 | 161,458.00 |
| Jun 30, 2018 | 163,333.00 |
| Mar 31, 2018 | 120,625.00 |
| Dec 31, 2017 | 49,125.00 |
| Sep 30, 2017 | 41,417.00 |